Trinity Biotech | TRIB - Selling And Administration Expenses

Stock Price
0.64
Daily Change
-0.02 -3.52%
Monthly
5.62%
Yearly
-9.45%
Q2 Forecast
0.62

Trinity Biotech reported $6.19M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Bayer EUR 4.05B 647M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
EDAP TMS EUR 8.81M 1.57M Sep/2025
J&J USD 6.03B 719M Mar/2026
Mesa Laboratories USD 27.31M 380K Sep/2024
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Siemens EUR 3.61B 489M Dec/2025
Surmodics USD 11.4M 3.18M Jun/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Tosoh JPY 41.52B 2.62B Dec/2025
Trinity Biotech USD 6.19M 2.18M Sep/2025
Veracyte USD 43.31M 8.43M Dec/2025